Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
339
-
Total 13F shares, excl. options
-
29.3M
-
Shares change
-
+746K
-
Total reported value, excl. options
-
$5.81B
-
Value change
-
+$152M
-
Put/Call ratio
-
0.9
-
Number of buys
-
171
-
Number of sells
-
-167
-
Price
-
$198.54
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q2 2020
399 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q2 2020.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 339 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.3M shares
of 33M outstanding shares and own 88.7% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4M shares), VANGUARD GROUP INC (3.07M shares), WELLINGTON MANAGEMENT GROUP LLP (1.92M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.52M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (987K shares), JPMORGAN CHASE & CO (981K shares), STATE STREET CORP (777K shares), RIVERBRIDGE PARTNERS LLC (672K shares), DIMENSIONAL FUND ADVISORS LP (672K shares), and WELLS FARGO & COMPANY/MN (625K shares).
This table shows the top 339 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.